반응형
| 구분 | 보고서(영문) |
| 제약/바이오/임상시험 (8건) |
US’s First Self-Administered Flu Vaccine Could Increase Accessibility and Uptake |
| Sanofi/Regeneron’s Dupixent Set to Dominate COPD Biologics Market Following FDA Approval | |
| Emerging Market Outsourcing Report – Q3 2024 | |
| Asia-Pacific Dominates For Endometriosis Trials | |
| Keytruda and Opdivo: A Decade Review | |
| Crucial Drug Shortages Initiate Call for Action to Include Pregnant Women in Clinical Trials | |
| A Schizophrenia Win for BMS’s Cobenfy, But Challenges Lie Ahead | |
| Bio/Pharmaceutical Outsourcing Report, September 2024 | |
| 컨퍼런스/심포지엄/학회/기타 (2건) | ERS 2024 Congress: The Future of the COPD Landscape |
| Global Leaders Set Targets to Combat AMR at UN High-Level Meeting | |
| 질환별 (9건) |
Glycogen Storage Disorders: Competitive Landscape |
| Multiple System Atrophy: Competitive Landscape | |
| Physicians Highlight Need for Improved Non-Opioid Treatments for Opioid Use Disorder | |
| Neffy Nasal Spray: A Game Changer for Asthma Patients and Epinephrine Delivery? | |
| Gonorrhea: Competitive Landscape | |
| HER2+ Breast cancer: Eight-Market Drug Forecast | |
| Sepsis: Epidemiology Forecast to 2033 | |
| Lebrikizumab, Tralokinumab, and Dupilumab to Compete in Atopic Dermatitis | |
| Pediatric Type 2 Diabetes Faces Significant Underdiagnosis in China |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 11.08. (금) (0) | 2025.01.06 |
|---|---|
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 10.25. (금) (0) | 2025.01.06 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 9.27. (금) (0) | 2025.01.06 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 9.13. (금) (0) | 2024.09.15 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.30. (금) (1) | 2024.09.15 |